Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
This phase II study of 25 patients with refractory aplastic anemia found that treatment with an oral thrombopoietin mimetic, eltrombopag was associated with multilineage clinical responses. Eleven (44%) had a hematologic response in at least one lineage at 12 weeks, with minimal side effects. Of these, nine patients no longer needed platelet transfusion support, three patients became red cell transfusion independent, and nine patients had increased neuthrophil count.
– Lawrence Tim Goodnough
NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther heathcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.